Scott Heller - Concepedia

Author

Scott Heller

Amgen (United States)

Also Known As

S Heller, Scott F Heller, Scott Heller

Publications

908

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Northwestern University

About

Scott Heller is an author at Amgen (United States) specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	370
2	Cell Biology	2	2	193
3	Natural Sciences	1	1	20
4	Biochemistry	1	1	20
5	Gastroenterology	1	1	64

Scott Heller

Publications

835

Citations

H-Index

Page 1

	Year	Citations
FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis Han‐Xiang Deng, Hong Zhai, Eileen H. Bigio, Annals of Neurology	2010	346
Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. M Remacle-Bonnet, Françoise Garrouste, Scott Heller, PubMed ApoptosisImmunologyDeath FactorsPathologyCell Death	2000	138
Availability of related donors for bone marrow transplantation in sickle cell anemia. W C Mentzer, Scott Heller, P R Pearle, PubMed	1994	119
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 Kreshnik Ahmeti, Senda Ajroud‐Driss, Ammar Al‐Chalabi, Neurobiology of Aging Neurodegenerative DiseasesAmyotrophic Lateral SclerosisNeurological DisorderGeneticsDegenerative Disease	2012	93
Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: A retrospective study of complications and outcome Jeffrey A. Allen, Richard J. Chen, Senda Ajroud‐Driss, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Retrospective StudyRadiologyEsophagusInterventional Endoscopic UltrasoundPatient Safety	2013	64
AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models Tammy L. Bush, Marc Payton, Scott Heller, Molecular Cancer Therapeutics Amg 900Chemoprevention StrategyMedicineReceptor Tyrosine KinaseSmall Molecules	2013	55
The optimization of aminooxadiazoles as orally active inhibitors of Cdc7 Paul E. Harrington, Matthew P. Bourbeau, Christopher Fotsch, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineActive InhibitorsNatural Sciences	2013	20

Page 1